menu close
www.remixtx.com

Remix Therapeutics Stock

Company Profile:

Remix Therapeutics focuses on developing small molecule therapies to modulate RNA processing, aiming to address underlying drivers of diseases with high unmet medical needs. The company leverages its proprietary REMaster platform to design molecules that can alter RNA expression, targeting diseases such as cancer and genetic disorders, with multiple programs advancing toward clinical trials.

Sign up for SecondMarket® to view the market and buy or sell Remix Therapeutics Stock
Buy + Sell
  • Headquarters: Watertown, MA
  • Year Founded: 2019
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

Remix Therapeutics Management Team

  • Board Member

    Scott Biller

  • Board Member

    Kevin Bitterman

  • Co-Founder, President, CEO

    Peter Smith

  • Chief Scientific Officer

    Dominic Reynolds

  • Board Member

    Jeff Goater

  • Board Member

    Matthew R. Patterson

  • Board Member

    Michael Rome

  • CFO

    Robert Gagnon

  • COO

    Heather Wasserman

Learn More About Remix Therapeutics Stock

Buy Remix Therapeutics Stock
01

Remix Therapeutics stock does not trade on public stock exchanges. Remix Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Remix Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Remix Therapeutics Stock
02

Remix Therapeutics Stock does not trade on public stock exchanges. In order to sell Remix Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Remix Therapeutics Stock Price
03

Remix Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Remix Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Remix Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for Remix Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Remix Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Remix Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Remix Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Remix Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Remix Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Remix Therapeutics IPO
08

Remix Therapeutics is a private company and has not had an IPO. There is currently no Remix Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Remix Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Remix Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Curology-Logo

Curology

Offers personalized prescription skin care medications delivered directly to you.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Source: Nasdaq Private Market Tape D®